Inhibition of glycogen phosphorylase (GP) can be a new therapeutic method for the treatment of type 2 diabetes mellitus, and potential application of GP inhibitors (GPIs) in some other diseased states, such as early cardiac and cardiovascular disorders in non-diabetics, cardiac arrhythmias, ischemic injuries, and tumor growth was also proposed. [1] [2] [3] [4] [5] A large array of compounds was shown to have inhibitory effect against GP under in vitro conditions. 4, 6 Among these molecules glucose derivatives are the most intensively investigated GPIs, and detailed studies can be found in the literature on their structure-activity relationships (SAR). 5,7 50 Some glucose derived GPIs had in vivo hypoglycaemic 8 and other interesting physiological effects. 9 Widely studied glucose analogue GPIs are derivatives of b-D-glucopyranosylamine, such as N-acyl-b-D-glucopyranosylamines [10] [11] [12] [13] (I in Chart 1, e.g., K i = 10-13 lM 11,14 against rabbit muscle GPb (RMGPb) 15 for R = 2-naphthyl), N-aryl-N 0 -b-D-glucopyranosyl ureas 4 (II, e.g., K i = 5.2 lM (RMGPb) for R = 2-naphthyl), as well as N-acyl-N 0 -b-D-glucopyranosyl urea derivatives 4, 16 (III, e.g., K i = 0.35 lM (RMGPb) for R = 2-naphthyl) which inhibited the enzyme in or below the low micromolar range. Micromolar efficiency 60 was reported also for 4-(b-D-glucopyranosyl)thiosemicarbazones of aromatic aldehydes 17, 18 (IV X = S, e.g., IC 50 = 5.7 lM (RMGPb) for Ar = 4-fluorophenyl) . Compounds V, in which the sugar and the aromatic parts are interchanged in comparison to IV, have very recently been shown to be GPIs (K i = 29 lM for V X = O, and K i = 300 lM for V X = S against RMGPb). 19 Replacement of the NHCO moiety by 1,2,3-triazole (a nonclassical bioisosteric heterocyclic linker A) in molecules I resulted in effective GP inhibitors 20 (IA, e.g., K i = 16 lM (RMGPb) for R = 2-naphthyl). Enzymatic tests and crystallographic studies have 70 shown high similarity of the amide (I) and the 1,2,3-triazole (IA) type molecules both in binding strength and structural features of the enzyme-inhibitor complexes. 14 Replacement of the NHCO moiety with isomeric oxadiazoles B, C, and D resulted in inhibitors IB-D with varying efficiency. Among these molecules the 3-aryl-5b-D-glucopyranosyl-1,2,4-oxadiazoles IC proved to be the most effective compounds (e.g., K i = 2.4 lM(RMGPb) for R = 2-naphthyl). 21, 22 Bioisosteric replacement studies were also carried out with compounds III. 13, 19, 23 As part of a program to systematically replace NHCO moieties of 80 GPIs I-III by heterocyclic bioisosteres, herein we report on the syntheses and enzymatic tests of a series of 2-(b-D-glucopyranosylamino)-5-substituted-1,3,4-oxadiazoles IIB.
For the construction of 1,3,4-oxadiazole rings from acyclic precursors acidic treatment of N,N 0 -diacyl-(or N-acyl-N 0 -thioacyl)hydrazines as well as oxidative cyclization of acylhydrazones are the most frequently used procedures, and both methods were applied for the syntheses of 2-amino-5-substituted-1,3,4-oxadiazoles, too. 24 2-Glycosylamino-5-substituted-1,3,4-oxadiazoles are also known and have been synthesized from glycosyl isothiocya-90 nates either by the addition of acid hydrazides followed by ring 0008-6215/$ -see front matter Ó 2013 Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.carres.2013.04.025 closure of the resulting 1-acyl-4-glycosyl-thiosemicarbazides [25] [26] [27] or by chlorination to give intermediate glycosyl isocyanide dichlorides to be cyclized with acid hydrazides. 28 In this work we investigated the synthesis of compounds IIB from aldehyde 4-glycosyl-semicarbazones (cf. O-protected IV X = O in Chart 1), a route which, to the best of our knowledge, has not yet been applied to obtain 2-glycosylamino-1,3,4-oxadiazoles. On the other hand, the preparation of semicarbazones IV (X = O) gave the opportunity to compare their GPI properties to 100 the corresponding thiosemicarbazones IV (X = S).
Results and discussion

Syntheses
For the formation of the target oxadiazoles oxidative ring closure of aromatic aldehyde 4-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)semicarbazones (similar to that applied for the syntheses of 2-aryl-5-(2,3,4,6-tetra-O-benzoyl-b-D-glucopyranosyl)-1,3,4-oxadiazoles 22 ) was envisaged as the key step. To this end, O-peracetylated 4-(b-D-glucopyranosyl)semicarbazide 2 was prepared (Scheme 1) by the reaction of glucopyranosyl isocyanate 110 1 29 (obtained from the corresponding glucopyranosylamine 30 ) with hydrazine reagents under different reaction conditions (reagents: NH 2 NH 2 ÁHCl, NH 2 NH 2 ÁHOAc; solvents: dry pyridine, dry CH 2 Cl 2 , and 1 equiv Et 3 N). The best yield (75%) was achieved with NH 2 NH 2 ÁHOAc in dry CH 2 Cl 2 in the presence of Et 3 N. In each of the above reactions bis-glucopyranosyl urea was also isolated in various amounts which could be due to the presence of traces of water in the mixtures. 31 In order to get semicarbazones 3-9 condensation of semicarbazide 2 with the proper aldehydes was planned. However, 120 reactions of 2 with 2-napthaldehyde in dry EtOH or dry toluene in the presence of catalytic amounts of either AcOH or CF 3 COOH at reflux temperature resulted in complex reaction mixtures. Therefore, b-D-glucopyranosyl isocyanate 2 was reacted with aldehyde hydrazones 32 in boiling dry dioxane to result in the target molecules 3-9 in good yields. Debenzoylations were performed by the Zemplén protocol to give excellent yields of semicarbazones 10-16.
Ring closing reactions of the precursors under oxidative conditions were studied next. Semicarbazones 3, 5-7, and 9 were 
Enzyme inhibition studies
The kinetic parameters (inhibition potency against rabbit muscle glycogen phosphorylase b (RMGPb)) of the deprotected compounds were determined according to the protocol described earlier. 34 The results are summarized in Table 1 showing the inhibitory efficiency of some relevant reference compounds, as well.
Type IV semicarbazones 10-16, the 'open chain' precursors of the target compounds of this work, proved low micromolar inhibitors with the practically equipotent 4-nitrophenyl (12) and 170 2-naphthyl (16) compounds as the best ones. The strong binding of 16 fits the general trend observed with several glucose derivatives exhibiting most efficient inhibition with large hydrophobic groups in the aglycons. 4 A comparison to the structurally related thiosemicarbazone counterparts would be possible for the pairs 12-31, 13-32, and 14-33, however, the reported inhibition data 18 for the sulfur containing compounds 31-33 are IC 50 values not directly comparable with the inhibitor constants. Nevertheless, it is interesting to note that the tendency is different in the two series: within semicarbazones the 4-nitrophenyl (12) compound while within the thiosemicarbazones the 4-fluorophenyl (32) derivative proved $4 to 6 times stronger inhibitors than the next best ones 14 and 33, respectively.
A comparison of inhibition of 10 to that of the biuret type compound 37, 4 having the same number of atoms between the sugar and the aromatic ring, indicates the latter to be a $twice better inhibitor than the former one. This may underline the importance of both carbonyl units in the binding. On the other hand, 10 binds $15-fold stronger than 38 4 with two C@O moieties but also having a rotatable CH 2 unit in place of NH, thereby emphasizing that the 190 rigidity of 10 makes an important contribution to the binding.
A further comparison of 10 to type V compound 39, 19 wherein the semicarbazone linker is formally reversed between the carbohydrate ring and the phenyl group, shows a moderate strengthening of the inhibition that may refer to the higher contribution of the second carbonyl unit to the binding. This is corroborated by the smaller decrease caused by the change 37?39 than that of 37?10. A formal reversal of the thiosemicarbazone linker as in 40 19 makes a very large decrease in the binding strength most probably because the thiocarbonyl in the position 200 of the 'second amide' moiety is much less suitable to make strong interactions to the enzyme.
Replacement of the NHCO moiety in compounds type II by the 1,3,4-oxadiazole ring (compounds type IIB: 24-30) resulted in moderate GPIs. For the phenyl and 1-naphthyl substituted pairs 34-24 and 35-29 there is no significant change in the binding strength. Substitution in the 4-position of the aromatic ring (25-27) resulted in a small and unspecific increase of the efficiency, while the 3-chloro replacement (28) made a somewhat weaker inhibitor. Based on these results one could argue that the 1,3,4-oxa-210 diazole is an acceptable bioisosteric replacement of the NHCO moiety in this system. However, this argument is weakened by the $5 times worse inhibition of 30 as compared to 36 for which a speculative explanation can be that the large and rigid aglycon is unable to find an accomodatable position in the binding site of the enzyme. was complete (TLC 1:1 EtOAc/hexane) the reaction mixture was filtered with suction, and the solvent was evaporated under reduced pressure. The crude product was purified by column chromatography. 
Conclusion
